Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125

Genes to Cells

Volumn 11, Issue 9, 2006, Pages 983-992

  Wang, Bin ^a,b   Tsukada, Junichi ^a,c   Higashi, Takehiro ^a   Mizobe, Takamitsu ^a   Matsuura, Ai ^a   Mouri, Fumihiko ^a   Sawamukai, Norifumi ^a   Ra, Chisei ^d   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c School of Medicine   (Japan)

^d NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE TRIPHOSPHATE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 9 INHIBITOR; CYCLIN D3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; STEM CELL FACTOR RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; CATALYSIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MAST CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION;

ANTHRACENES; APOPTOSIS; CASPASE 3; CASPASE 9; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D3; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAST CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-KIT; TIME FACTORS;

EID: 33747472533     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2006.01005.x     Document Type: Article

References (44)

1. Akin, C. & Metcalfe, D.D. (2004) The biology of Kit in disease and the application of pharmacogenetics. J. Allergy Clin. Immunol. 114, 13-19.
2. Ashman, L.K. (1999) The biology of stem cell factor and its receptor C-kit. Int. J. Biochem. Cell Biol. 31, 1037-1051.
3. Bakiri, L., Lallemand, D., Bossy-Wetzel, E. & Yaniv, M. (2000) Cell cycle-dependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression. EMBO J. 19, 2056-2068.
4. Bartek, J., Bartkova, J. & Lukas, J. (1996) The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8, 805-814.
5. Bennett, B.L., Sasaki, D.T., Murray, B.W., O'Leary, E.C., Sakata, S.T., Xu, W., Leisten, J.C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S.S., Manning, A.M. & Anderson, D.W. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98, 13681-13686.
6. Capeans, C., Pineiro, A., Dominguez, F., Loidi, L., Buceta, M., Carneiro, C., Garcia-Caballero, T. & Sanchez-Salorio, M. (1998) A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation. Exp. Eye Res. 66, 581-589.
7. Chian, R., Young, S., Danilkovitch-Miagkova, A., Ronnstrand, L., Leonard, E., Ferrao, P., Ashman, L. & Linnekin, D. (2001) Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant. Blood 98, 1365-1373.
8. Davis, R.J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
9. Deng, Y., Ren, X., Yang, L., Lin, Y. & Wu, X. (2003) A JNK-dependent pathway is required for TNFα-induced apoptosis. Cell 115, 61-70.
10. Derijard, B., Hibi, M., Wu, I.H., Barrett, T., Su, B., Deng, T., Karin, M. & Davis, R.J. (1994) JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
11. Dickens, M., Rogers, J.S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J.R., Greenberg, M.E., Sawyers, C.L. & Davis, R.J. (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277, 693-696.
12. Dunn, C., Wiltshire, C., MacLaren, A. & Gillespie, D.A. (2002) Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell. Signal. 14, 585-593.
13. Ezhevsky, S.A., Nagahara, H., Vocero-Akbani, A.M., Gius, D.R., Wei, M.C. & Dowdy, S.F. (1997) Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D: Cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. USA 94, 10699-10704.
14. Foltz, I.N. & Schrader, J.W. (1997) Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89, 3092-3096.
15. Frost, M.J., Ferrao, P.T., Hughes, T.P. & Ashman, L.K. (2002) Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant. Mol. Cancer Ther. 1, 1115-1124.
16. Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J.H., Ashman, L.K. & Kanayama, Y. (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J. Clin. Invest. 92, 1736-1744.
17. Galli, S.J., Zsebo, K.M. & Geissler, E.N. (1994) The kit ligand, stem cell factor. Adv. Immunol. 55, 1-96.
18. Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Muhammad Tunio, G., Matsuzawa, Y., Kanakura, Y., Shinomura, Y. & Kitamura, Y. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580.
19. Iemura, A., Tsai, M., Ando, A., Wershil, B.K. & Galli, S.J. (1994) The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am. J. Pathol. 144, 321-328.
20. Itakura, A., Miura, Y., Hikasa, Y., Kiso, Y. & Matsuda, H. (2001) Interleukin-3 and stem cell factor modulate cell cycle regulatory factors in mast cells: Negative regulation of p27Kip1 in proliferation of mast cells induced by interleukin-3 but not stem cell factor. Exp. Hematol. 29, 803-811.
21. Kawakami, Y., Hartman, S.E., Holland, P.M., Cooper, J.A. & Kawakami, T. (1998) Multiple signaling pathways for the activation of JNK in mast cells: Involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7. J. Immunol. 161, 1795-1802.
22. Kyriakis, J.M. & Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869.
23. Lockshin, R.A. & Zakeri, Z. (2002) Caspase-independent cell deaths. Curr. Opin. Cell Biol. 14, 727-733.
24. Longley, B.J., Tyrrell, L., Lu, S.Z., Ma, Y.S., Langley, K., Ding, T.G., Duffy, T., Jacobs, P., Tang, L.H. & Modlin, I. (1996) Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat. Genet. 12, 312-314.
25. Ma, Y., Zeng, S., Metcalfe, D.D., Akin, C., Dimitrijevic, S., Butterfield, J.H., McMahon, G. & Longley, B.J. (2002) The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99, 1741-1744.
26. Mekori, Y.A., Oh, C.K. & Metcalfe, D.D. (1993) IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J. Immunol. 151, 3775-3784.
27. Nagata, H., Worobec, A.S., Oh, C.K., Chowdhury, B.A., Tannenbaum, S., Suzuki, Y. & Metcalfe, D.D. (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl. Acad. Sci. USA 92, 10560-10564.
28. Nilsson, G. & Metcalfe, D.D. (1996) Contemporary issues in mast cell biology. Allergy Asthma Proc. 17, 59-63.
29. 816 mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells. Blood 97, 3559-3567.
30. Prendergast, G.C. (1999) Mechanisms of apoptosis by c-Myc. Oncogene 18, 2967-2987.
31. Rodrigues, G.A., Park, M. & Schlessinger, J. (1997) Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J. 16, 2634-2645.
32. Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P. & Wagner, E.F. (1999) Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607-619.
33. Sherr, C.J. (2000) The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res. 60, 3689-3695.
34. Smeal, T., Binetruy, B., Mercola, D.A., Birrer, M. & Karin, M. (1991) Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494-496.
35. Sundstrom, M., Vliagoftis, H., Karlberg, P., Butterfield, J.H., Nilsson, K., Metcalfe, D.D. & Nilsson, G. (2003) Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology 108, 89-97.
36. Tanaka, A., Konno, M., Muto, S., Kambe, N., Morii, E., Nakahata, T., Itai, A. & Matsuda, H. (2005) A novel NF-κB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors. Blood 105, 2324-2331.
37. Tanaka, Y., Nakayamada, S., Fujimoto, H., Okada, Y., Umehara, H., Kataoka, T. & Minami, Y. (2002) H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts. J. Biol. Chem. 277, 21446-21452.
38. Tian, Q., Frierson, H.F. Jr, Krystal, G.W. & Moskaluk, C.A. (1999) Activating c-kit gene mutations in human germ cell tumors. Am. J. Pathol. 154, 1643-1647.
39. Timokhina, I., Kissel, H., Stella, G. & Besmer, P. (1998) Kit signaling through PI 3-kinase and Src kinase pathways: An essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J. 17, 6250-6262.
40. Tournier, C., Hess, P., Yang, D.D., Xu, J., Turner, T.K., Nimnual, A., Bar-Sagi, D., Jones, S.N., Flavell, R.A. & Davis, R.J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874.
41. Wiltshire, C., Matsushita, M., Tsukada, S., Gillespie, D.A. & May, G.H. (2002) A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem. J. 367, 577-585.
42. Wisdom, R., Johnson, R.S. & Moore, C. (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18, 188-197.
43. Yarden, Y., Kuang, W.J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T.J., Chen, E., Schlessinger, J., Francke, U. & Ullrich, A. (1987) Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6, 3341-3351.
44. Zermati, Y., De Sepulveda, P., Feger, F., et al. (2003) Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene 22, 660-664.